Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Supply Of Exclusive Drugs With Active Ingredients Avalglucosidase Alfa, Vandetanib, Imigluceras, Dupilumab, Rasburicasa And Sarilumab Of The Pharmaceutical Laboratory Sanofi Aventis, S.A For The Centers Dependent On The Murcian Health Service.

Servicio Murciano de Salud - Junta de Compras Spain has Released a tender for Supply Of Exclusive Drugs With Active Ingredients Avalglucosidase Alfa, Vandetanib, Imigluceras, Dupilumab, Rasburicasa And Sarilumab Of The Pharmaceutical Laboratory Sanofi Aventis, S.A For The Centers Dependent On The Murcian Health Service. in Pharmaceuticals. The tender was released on Jun 27, 2025.

Country - Spain

Summary - Supply Of Exclusive Drugs With Active Ingredients Avalglucosidase Alfa, Vandetanib, Imigluceras, Dupilumab, Rasburicasa And Sarilumab Of The Pharmaceutical Laboratory Sanofi Aventis, S.A For The Centers Dependent On The Murcian Health Service.

Deadline - login to view

GT reference number - 112093239

Product classification - Medicinal products for the alimentary tract and metabolism

Organization Details:

  Address - Spain

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 112093239

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply of exclusive drugs with active ingredients Avalglucosidase Alfa, Vandetanib, Imigluceras, Dupilumab, Rasburicasa and Sarilumab of the Pharmaceutical Laboratory Sanofi Aventis, S.A for the centers dependent on the Murcian Health Se rvice.local title:: Suministro de fármacos exclusivos con principios activos avalglucosidasa alfa, vandetanib, imiglucerasa, dupilumab, rasburicasa y sarilumab del laboratorio farmacéutico SANOFI AVENTIS, S.A para los centros dependientes del servicio murciano de salud.Contract Type: : Supplylocal description: : Suministro de fármacos exclusivos con principios activos avalglucosidasa alfa, vandetanib, imiglucerasa, dupilumab, rasburicasa y sar

Gt Ref Id - 112093239

Deadline - Nov 30, -0001

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database